Company Overview - Rush Street Interactive, Inc. (RSI) is a leading online casino and sports betting company operating in the United States and the Americas [3] - The company offers real-money mobile and online operations in fifteen U.S. states and several international markets including Colombia, Ontario, Mexico, and Peru [3] - RSI operates under brands such as BetRivers, PlaySugarHouse, and RushBet, and has been recognized with multiple awards for customer service and operational excellence [3] Upcoming Event - Richard Schwartz, CEO, and Kyle Sauers, CFO of RSI will participate in a fireside chat at Oppenheimer's Technology, Internet & Communications Conference on August 13 at 9:55 a.m. Eastern Time [1] - Access to the webcast will be available through the "Investors" section of RSI's website, with a replay archived for 90 days [2]

NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Yocan, a leader in vaporizer technology, today refined its bestselling battery platform with the Lux 2.0 Series, proving meaningful innovation doesn't require reinventing the wheel. While retaining the signature top-twist voltage control (1.8V-4.2V) users expect, the new generation introduces first-ever OLED smart display and precision-engineered preheat system. What’s Actually New: OLED Display - Real-time voltage/puff/battery tracking (previously hidden metrics ...

Sdot Dan becomes the latest regional council in central Israel to implement the SaverOne System to protect school children Petah Tikvah, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company specializing in developing transportation safety solutions, today announced that the Sdot Dan Regional Council in Israel has signed an agreement to install the SaverOne system on its fleet of buses which transport students to their schools. Sdot Dan joins a group ...

Core Viewpoint - Verb Technology Company, Inc. has successfully closed a $558 million private placement to support the acquisition of Toncoin, the native cryptocurrency of The Open Network blockchain, aiming to become the largest publicly traded treasury reserve of Toncoin [1][3]. Company Strategy - The majority of the net proceeds from the PIPE transaction will be used to acquire Toncoin, which will serve as the primary treasury reserve asset for the company [3]. - The company plans to generate sustainable staking rewards from its Toncoin holdings to manage and grow its exposure in a cash flow positive manner [3]. - Verb Technology Company intends to rebrand as TON Strategy Co. to reflect its new focus on digital assets while continuing to operate its existing business units [3]. Investment Participation - The PIPE transaction involved approximately 58.7 million shares of common stock and participation from over 110 institutional and crypto-native investors, including notable firms such as Vy Capital, Blockchain.com, and Ribbit Capital [2]. - The transaction was led by Kingsway Capital, which played a significant role in the placement [2]. Leadership and Advisory Team - The company will be led by a team with extensive experience in digital assets, including Executive Chairman Manuel Stotz, who has over 15 years of investment experience in the blockchain ecosystem [5]. - CEO Veronika Kapustina has a background in capital markets and blockchain, having previously served as a Senior Advisor to the TON Foundation [5]. - CFO Sarah Olsen brings expertise from her previous role at JP Morgan, focusing on blockchain and tokenized assets [5]. Company Overview - Verb Technology Company operates in the social commerce space, leveraging technology and video marketing to enhance customer engagement and conversion rates [7]. - The company has developed a multi-vendor, livestream social shopping platform, integrating advanced AI capabilities for content creation and audience interaction [7].

Core Viewpoint - Capricor Therapeutics is advancing its lead cell therapy candidate, Deramiocel, for treating cardiomyopathy associated with Duchenne muscular dystrophy (DMD) and has scheduled a Type A meeting with the FDA to discuss its regulatory path for the Biologics License Application (BLA) [1][4][7] Financial Results and Corporate Update - The release of Capricor's financial results for the second quarter ended June 30, 2025, has been rescheduled to August 11, 2025, after market close [2][3] - A conference call and webcast will be held on the same day at 4:30 p.m. ET to review the financial results and provide a corporate update [2][3] Company Overview - Capricor Therapeutics focuses on developing cell and exosome-based therapeutics for rare diseases, with Deramiocel being a key product candidate showing immunomodulatory and anti-fibrotic effects in muscular dystrophies [4] - The company is also utilizing its proprietary StealthX™ platform for preclinical development in areas such as vaccinology and targeted delivery of therapeutics [4] Commercialization Agreement - Capricor has entered into an exclusive agreement with Nippon Shinyaku Co., Ltd. for the commercialization and distribution of Deramiocel for DMD in the United States and Japan, pending regulatory approval [7]

Core Viewpoint - Standard Lithium Ltd. has made significant progress in its lithium development projects, particularly the South West Arkansas (SWA) Project, and is on track for a Final Investment Decision by the end of 2025 [2][7]. Financial and Operational Highlights - As of June 30, 2025, the company reported cash and working capital of $33.8 million and $30.6 million, respectively, with no term or revolving debt obligations [13]. - The Arkansas Oil and Gas Commission approved a 2.5% royalty rate for Phase I of the SWA Project, marking a precedent for lithium development in Arkansas [4]. - The SWA Project achieved the highest lithium concentration reported to date from the area, with a sample showing 616 mg/L lithium in brine [3]. Project Development Milestones - The company completed all fieldwork for the first phase of the SWA Project and is advancing discussions on off-take and project financing [2]. - A Definitive Feasibility Study for the SWA Project and a Maiden Inferred Resource Report for East Texas properties are expected to be released in the third quarter of 2025 [3]. - The SWA Project received special designation as a critical mineral production project under Executive Order 14241, emphasizing its importance to U.S. mineral production [5]. Management and Strategic Developments - The company strengthened its senior management team with new appointments, including Daniel Rosen as Vice President of Strategy and Investor Relations and Tim Sobel as Vice President of Health, Safety, Social and Environment [8]. - Standard Lithium is advancing next-generation solid-state battery materials in partnership with Telescope Innovations Corp., utilizing a new conversion process for lithium hydroxide [6].

Myseum, Inc.’s common stock and Series A warrants to begin trading on Nasdaq under the new trading symbols "MYSE" and “MYSEW”, respectively, effective August 11, 2025 Social group media sharing platform upgrade will make it easier to share and preserve photos and videos now and with future generations NEW BRUNSWICK, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DatChat, Inc. (Nasdaq: DATS) (“DatChat” or the “Company”), a security- and privacy-first social media and technology company, today announced a rebrandin ...

SINGAPORE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (NASDAQ: TDTH), a Singapore-based leader in digital transformation and Web 3.0 activation, today announced plans to pursue regulatory approvals for stablecoin operations across several African countries. The initiative aims to accelerate adoption of Ripple USD (RLUSD) – Ripple’s U.S. dollar–pegged stablecoin – to enhance financial inclusion and digital payments infrastructure on the continent. Strategic BackgroundTDTH recently to ...

Group 1 - Altus Group Limited announced a cash dividend of $0.15 per common share for Q3 ending September 30, 2025, payable on October 15, 2025 [1] - The Dividend Reinvestment Plan (DRIP) allows eligible shareholders to reinvest cash dividends in additional common shares at 96% of the weighted average closing price for the five trading days preceding the payment date [2] - All dividends paid to common shareholders qualify as "eligible dividends" under Canadian tax legislation [3] Group 2 - Altus Group is a leading provider of commercial real estate intelligence, connecting data, analytics, and expertise to enhance CRE performance [4] - The company employs approximately 2,000 experts who contribute to shaping urban environments and communities [4]

Core Viewpoint - Assembly Biosciences, Inc. has announced a registered offering of common stock and warrants, aiming to raise capital for its innovative therapeutics targeting serious viral diseases [1][4]. Group 1: Offering Details - The offering consists of 5,591,840 shares of common stock and pre-funded warrants for 1,040,820 shares, with a combined price of $19.60 per share and accompanying warrants [1]. - Each pre-funded warrant has a nominal exercise price of $0.001 and is immediately exercisable, while Class A and Class B warrants have an exercise price of $21.60 and specific expiration conditions [1]. - The offering and a private placement with Gilead Sciences, Inc. are expected to close on August 11, 2025, contingent upon customary closing conditions [4]. Group 2: Investor Participation - The offering includes participation from both new and existing investors, such as Commodore Capital, Blackstone Multi-Asset Investing, and Farallon Capital Management [2]. - Gilead will purchase 2,295,920 shares in a private placement at the same price as the offering, which will not be registered under the Securities Act [3]. Group 3: Use of Proceeds - The net proceeds from the offering and private placement will be utilized for general corporate purposes [4]. Group 4: Company Overview - Assembly Biosciences is focused on developing small-molecule therapeutics aimed at serious viral diseases, including herpesvirus and hepatitis infections [7][8].